Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

NOBELPHARMA AMERICA — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report (No Activity)

NOBELPHARMA AMERICA

via M.J. SIMON & COMPANY, LLC

4th Quarter (Oct 1 - Dec 31) · 2021Posted Jan 19, 2022Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: NOBELPHARMA AMERICA
Description: Pharmaceutical manufacturer
Location: Maryland · United States of America

Registrant

Firm: M.J. SIMON & COMPANY, LLC
Description: Boutique firm specializing in health and human services policy
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.